Αποτελέσματα Αναζήτησης
Common side effects include permanent hypo- and hyperpigmentation, blistering, and postoperative pain [34], and a delay of approximately 3–4 weeks between sessions (approximately three to six sessions are needed) is often needed for post treatment healing [35, 36].
Ear keloids at their earliest stages appear in two distinct manners: 1. Protruding papule on the surface of ear. This is by far the most frequently observed form of ear keloid at the site of a previous piercing. Treatment Ear keloids that are diagnosed at this early-stage as protruding papule(s) (Figure 1) shall be first treated with ILT (See KRF
4 Απρ 2023 · It is important to warn patients that immediate radiotherapy following surgical excision of keloids is associated with predictable acute skin side effects of transient erythema, edema, scaling, ulceration, and even necrosis, in almost all patients within the first 7 to 10 days after treatment.
27 Οκτ 2023 · Among 56 treated keloids, 89.3% of them (50/56) did not recur during a follow-up period (from 6 up to 24 months, mean 16.3 months) while six keloids recurred (6/56, 10.7%) with mild thickening of the scar, thus requiring further treatments.
Various treatment options have been advocated as ways to prevent and treat keloid scars. These include noninvasive treatments such as use of silicone gel sheeting and compression therapy, and invasive treatments such as intralesional corticosteroid injections, surgery, and radiotherapy.
14 Μαρ 2023 · Subjects have generally shown flattening of their treated keloids with 59–77% showing > 50% flattening, with the highest percentages in those treated with a P-32 patch [91,92,93]. The side effects of treatment were radiation dermatitis, which was no different between the P-32 and Re-188 patches. Silicone and pressure
9 Σεπ 2020 · Future studies could target the efficacy of novel treatment modalities (i.e., autologous fat grafting or stem cell-based therapies) for keloid management. This review article provides updated treatment guidelines for keloids and discusses insight into management to assist patient-focused, evidence-based clinical decision making.
